Heart Disease Clinical Trials in California

Showing 21-40 of 217 trials

A Safety, Tolerability, and Biomarker Trial of VS-041 in Participants With Heart Failure With Preserved Ejection Fraction (HFpEF)

NCT07219511

A Safety, Tolerability, and Biomarker Trial of VS-041 in Participants with Heart Failure with Preserved Ejection Fraction (HFpEF)

HeartHeart Failure With Preserved Ejection Fraction (HFPEF)

Vasa Therapeutics42 participantsStarted Nov 2025

Little Rock, Arkansas, United States • Huntington Beach, California, United States • Santa Maria, California, United States +14 more locations

RECRUITING116 miles

Product Surveillance Registry

NCT01524276

The purpose of the Registry is to provide continuing evaluation and periodic reporting of safety and effectiveness of Medtronic market-released products. The Registry data is intended to benefit and support interests of patients, hospitals, clinicians, regulatory bodies, payers, and industry by streamlining the clinical surveillance process and facilitating leading edge performance assessment via the least burdensome approach.

Cardiac Rhythm DisordersUrological DisordersNeurological Disorders+13 more

Medtronic100,000 participantsStarted Jan 2012

Birmingham, Alabama, United States • Huntsville, Alabama, United States • Chandler, Arizona, United States +386 more locations

A Safety, Tolerability, and Biomarker Trial of VS-041 in Participants With Heart Failure With Preserved Ejection Fraction (HFpEF)

Product Surveillance Registry

Heart Disease Trials in Other Cities

A Study of Olezarsen (ISIS 678354) in Participants With Hypertriglyceridemia and Atherosclerotic Cardiovascular Disease, or With Severe Hypertriglyceridemia

Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease

A Phase III Study to Assess the Effect of AZD0780 on LDL-C in Patients With Clinical ASCVD or at Risk for a First ASCVD Event

Algorithm Using LINQ Sensors for Evaluation And Treatment of Heart Failure

ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack

A Study of LY3540378 in Participants With Worsening Chronic Heart Failure With Preserved Ejection Fraction (HFpEF)

Assessment of CCM in HF With Higher Ejection Fraction

A Study of Vericiguat (MK-1242) in Participants With Chronic Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-035)

Aventus Thrombectomy System Pulmonary Embolism Clinical Study

Multicenter Trial of ECMO in Children With Severe Cardiac Failure Using the Cardiohelp System

Comparison of Methods of Pulmonary Blood Flow Augmentation in Neonates: Shunt Versus Stent (The COMPASS Trial)

Diabetes-Centered Evaluation of Revascularization Strategy of Functional and Imaging-CombiNEd State-of-the-Art Percutaneous Coronary Intervention or Coronary-Artery Bypass Grafting in Patients With Diabetes Mellitus and Multivessel Coronary Artery Disease

Starlight Cardiovascular Lifeline Ductus Arteriosus Stent IDE Study

PIONEER III Trial to Assess Safety and Efficacy of the BuMA Supreme™ Drug Coated Coronary Stent in Patients With Coronary Disease

Equity in Modifying Plaque Of WomEn With UndeRtreated Calcified Coronary Artery Disease

REHAB Fontan Failure: A Trial of Cardiac Rehabilitation

Shockwave C2+ 2Hz Coronary IVL Catheter in Calcified Coronary Arteries (Disrupt CAD DUO)

A Study About How Blood Cell Growth Patterns Relate to Heart Health After Treatment for Hodgkin Lymphoma

Other Conditions in California